Heart Disease Trial, Recruiting NCT07439159 Sponsor: Istanbul University - Cerrahpasa Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07439159
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 years or older
  • People who have been admitted to hospital due to a sudden worsening of heart failure
  • People whose treating heart specialist has determined that diuretic medication given through a drip (intravenously) is needed
  • People whose heart failure is primarily affecting the left side of the heart
  • People who are willing and able to sign a written consent form before taking part

Who may not be able to join:

  • People with severely low red blood cell levels (very low haemoglobin)
  • People who require kidney dialysis (either haemodialysis or peritoneal dialysis) or who are on a waiting list for a kidney transplant
  • People with a severe leaking mitral valve (the valve between the upper and lower chambers on the left side of the heart) as the primary problem
  • People with a severely narrowed aortic valve
  • People with a severely leaking aortic valve
  • People with a severe leaking tricuspid valve as the primary problem
  • People whose heart failure is primarily affecting the right side of the heart
  • People whose heart failure is caused by a heart condition they were born with
  • People who have previously had their mitral valve replaced
  • People who have previously had their aortic valve replaced
  • People who have previously had any biological (tissue-based) heart valve replacement
  • People who have previously had a transcatheter aortic valve implantation (a type of minimally invasive valve procedure)
  • People with an active cancer diagnosis
  • People who are unable or unwilling to sign a written consent form
  • People for whom an ultrasound scan of the heart (echocardiogram) cannot be performed before starting intravenous diuretic treatment, for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +905356955610

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Istanbul University - Cerrahpasa
Registry
ClinicalTrials.gov
Start date
3 March 2024
Est. completion
1 August 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Time to Cardiovascular Death or Heart Failure-Related Rehospitalization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov